Microarray and microfluidic methodology for genotyping cytokine gene polymorphisms

Youvraj R. Sohni, James R Cerhan, Dennis O'Kane

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Cytokine genetic polymorphisms are the subject of disease-association studies that require large-scale human genotyping. Polymerase chain reaction based custom microarrays and microfluidics systems were used to develop genotyping assays for following cytokine polymorphisms: tumor necrosis factor-α G-308A, interleukin-4 (IL-4) C-589T, interferon-γ (CA)n repeats, IL-1RN 86-bp variable number of tandem repeats (VNTR), and CCR5 32-bp indel. For G-308A, 70.9% of DNA samples assayed were homozygous for wild type, 25.5% were heterozygous, and none were homozygous for variant allele. For C-589T, 35.5% of DNA samples were homozygous for wild type, 38% were heterozygous, and 22% were homozygous for variant. For IL-1RN VNTR, 71% of DNA samples were homozygous and the remainder were heterozygous. For CCR5, 96.4% of amplicons were homozygous for wild type, and 3.6% were heterozygous containing deletion. For IFN-γ (CA)n repeats, 35.6% had 2,2 alleles, 42.2% had 2,3 alleles, and 11% had 3,3 alleles with alleles 1 through 5 corresponding to 11 through 15 repeats, respectively. There was good concordance between the results we obtained and current "gold-standard" methodologies for analyzing single nucleotide polymorphisms and size polymorphisms. Electronic DNA concentration with high stringency predisposes microarray technology to hybridization fidelity and accuracy, and microfluidics systems outperform conventional methodologies for size polymorphisms. Comprehensive genotyping can be achieved for clinical epidemiologic studies on cytokine gene polymorphisms using this approach.

Original languageEnglish (US)
Pages (from-to)990-997
Number of pages8
JournalHuman Immunology
Volume64
Issue number10
DOIs
StatePublished - Oct 1 2003

Fingerprint

Microfluidics
Alleles
Cytokines
Minisatellite Repeats
Genes
DNA
Genetic Polymorphisms
Interleukin-4
Gold
Interferons
Single Nucleotide Polymorphism
Epidemiologic Studies
Tumor Necrosis Factor-alpha
Technology
Polymerase Chain Reaction

Keywords

  • Cytokines
  • Genotyping
  • Microarrays
  • Microfluidics
  • Polymorphisms

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Microarray and microfluidic methodology for genotyping cytokine gene polymorphisms. / Sohni, Youvraj R.; Cerhan, James R; O'Kane, Dennis.

In: Human Immunology, Vol. 64, No. 10, 01.10.2003, p. 990-997.

Research output: Contribution to journalArticle

Sohni, Youvraj R. ; Cerhan, James R ; O'Kane, Dennis. / Microarray and microfluidic methodology for genotyping cytokine gene polymorphisms. In: Human Immunology. 2003 ; Vol. 64, No. 10. pp. 990-997.
@article{234f84b232a54f0092dccc2b8ea852c7,
title = "Microarray and microfluidic methodology for genotyping cytokine gene polymorphisms",
abstract = "Cytokine genetic polymorphisms are the subject of disease-association studies that require large-scale human genotyping. Polymerase chain reaction based custom microarrays and microfluidics systems were used to develop genotyping assays for following cytokine polymorphisms: tumor necrosis factor-α G-308A, interleukin-4 (IL-4) C-589T, interferon-γ (CA)n repeats, IL-1RN 86-bp variable number of tandem repeats (VNTR), and CCR5 32-bp indel. For G-308A, 70.9{\%} of DNA samples assayed were homozygous for wild type, 25.5{\%} were heterozygous, and none were homozygous for variant allele. For C-589T, 35.5{\%} of DNA samples were homozygous for wild type, 38{\%} were heterozygous, and 22{\%} were homozygous for variant. For IL-1RN VNTR, 71{\%} of DNA samples were homozygous and the remainder were heterozygous. For CCR5, 96.4{\%} of amplicons were homozygous for wild type, and 3.6{\%} were heterozygous containing deletion. For IFN-γ (CA)n repeats, 35.6{\%} had 2,2 alleles, 42.2{\%} had 2,3 alleles, and 11{\%} had 3,3 alleles with alleles 1 through 5 corresponding to 11 through 15 repeats, respectively. There was good concordance between the results we obtained and current {"}gold-standard{"} methodologies for analyzing single nucleotide polymorphisms and size polymorphisms. Electronic DNA concentration with high stringency predisposes microarray technology to hybridization fidelity and accuracy, and microfluidics systems outperform conventional methodologies for size polymorphisms. Comprehensive genotyping can be achieved for clinical epidemiologic studies on cytokine gene polymorphisms using this approach.",
keywords = "Cytokines, Genotyping, Microarrays, Microfluidics, Polymorphisms",
author = "Sohni, {Youvraj R.} and Cerhan, {James R} and Dennis O'Kane",
year = "2003",
month = "10",
day = "1",
doi = "10.1016/S0198-8859(03)00174-5",
language = "English (US)",
volume = "64",
pages = "990--997",
journal = "Human Immunology",
issn = "0198-8859",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Microarray and microfluidic methodology for genotyping cytokine gene polymorphisms

AU - Sohni, Youvraj R.

AU - Cerhan, James R

AU - O'Kane, Dennis

PY - 2003/10/1

Y1 - 2003/10/1

N2 - Cytokine genetic polymorphisms are the subject of disease-association studies that require large-scale human genotyping. Polymerase chain reaction based custom microarrays and microfluidics systems were used to develop genotyping assays for following cytokine polymorphisms: tumor necrosis factor-α G-308A, interleukin-4 (IL-4) C-589T, interferon-γ (CA)n repeats, IL-1RN 86-bp variable number of tandem repeats (VNTR), and CCR5 32-bp indel. For G-308A, 70.9% of DNA samples assayed were homozygous for wild type, 25.5% were heterozygous, and none were homozygous for variant allele. For C-589T, 35.5% of DNA samples were homozygous for wild type, 38% were heterozygous, and 22% were homozygous for variant. For IL-1RN VNTR, 71% of DNA samples were homozygous and the remainder were heterozygous. For CCR5, 96.4% of amplicons were homozygous for wild type, and 3.6% were heterozygous containing deletion. For IFN-γ (CA)n repeats, 35.6% had 2,2 alleles, 42.2% had 2,3 alleles, and 11% had 3,3 alleles with alleles 1 through 5 corresponding to 11 through 15 repeats, respectively. There was good concordance between the results we obtained and current "gold-standard" methodologies for analyzing single nucleotide polymorphisms and size polymorphisms. Electronic DNA concentration with high stringency predisposes microarray technology to hybridization fidelity and accuracy, and microfluidics systems outperform conventional methodologies for size polymorphisms. Comprehensive genotyping can be achieved for clinical epidemiologic studies on cytokine gene polymorphisms using this approach.

AB - Cytokine genetic polymorphisms are the subject of disease-association studies that require large-scale human genotyping. Polymerase chain reaction based custom microarrays and microfluidics systems were used to develop genotyping assays for following cytokine polymorphisms: tumor necrosis factor-α G-308A, interleukin-4 (IL-4) C-589T, interferon-γ (CA)n repeats, IL-1RN 86-bp variable number of tandem repeats (VNTR), and CCR5 32-bp indel. For G-308A, 70.9% of DNA samples assayed were homozygous for wild type, 25.5% were heterozygous, and none were homozygous for variant allele. For C-589T, 35.5% of DNA samples were homozygous for wild type, 38% were heterozygous, and 22% were homozygous for variant. For IL-1RN VNTR, 71% of DNA samples were homozygous and the remainder were heterozygous. For CCR5, 96.4% of amplicons were homozygous for wild type, and 3.6% were heterozygous containing deletion. For IFN-γ (CA)n repeats, 35.6% had 2,2 alleles, 42.2% had 2,3 alleles, and 11% had 3,3 alleles with alleles 1 through 5 corresponding to 11 through 15 repeats, respectively. There was good concordance between the results we obtained and current "gold-standard" methodologies for analyzing single nucleotide polymorphisms and size polymorphisms. Electronic DNA concentration with high stringency predisposes microarray technology to hybridization fidelity and accuracy, and microfluidics systems outperform conventional methodologies for size polymorphisms. Comprehensive genotyping can be achieved for clinical epidemiologic studies on cytokine gene polymorphisms using this approach.

KW - Cytokines

KW - Genotyping

KW - Microarrays

KW - Microfluidics

KW - Polymorphisms

UR - http://www.scopus.com/inward/record.url?scp=0141754000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141754000&partnerID=8YFLogxK

U2 - 10.1016/S0198-8859(03)00174-5

DO - 10.1016/S0198-8859(03)00174-5

M3 - Article

C2 - 14522097

AN - SCOPUS:0141754000

VL - 64

SP - 990

EP - 997

JO - Human Immunology

JF - Human Immunology

SN - 0198-8859

IS - 10

ER -